Astec Lifesciences Ltd.
•₹ 601.850.01%
2026-08-21
PROS
- Promoters have been increasing their shareholding - up 5.2pp over 2 years
- Working capital cycle has improved - days down from -29 to -47
CONS
- Company is loss-making at the operating / net level
- Operating cash flow has been negative in recent years
- Company has a low return on equity of -27.6% over last 3 years
- Receivables are growing faster than sales - a possible quality concern
- Company has a low return on capital employed of -7.6%
- Interest coverage is weak at -1.3x - earnings barely cover interest
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | UPL | 568.70 | 23.77 | 48007.91 | 1.05 | -73.00 | 58.52 | 10181.00 | 10.47 | 12.00 | 13.43 |
| 2. | PIIND | 2496.00 | 32.51 | 37868.84 | 0.60 | 244.20 | -38.95 | 1702.30 | -10.43 | 16.00 | 21.69 |
| 3. | SUMICHEM | 553.65 | 47.69 | 27635.20 | 0.23 | 214.51 | 20.45 | 1063.35 | 0.62 | 23.39 | 21.94 |
| 4. | BAYERCROP | 4068.40 | 329.99 | 18284.24 | 3.69 | 321.60 | 15.39 | 1835.00 | -4.16 | 30.08 | 20.03 |
| 5. | SHARDACROP | 771.80 | 11.12 | 6963.22 | 1.94 | 88.02 | -38.36 | 1073.77 | 9.03 | 31.10 | 17.32 |
| 6. | DHANUKA | 995.20 | 14.94 | 4436.43 | 0.20 | 75.50 | 27.94 | 442.02 | 20.01 | 24.44 | 24.83 |
| 7. | RALLIS | 211.90 | 25.10 | 4120.80 | 1.42 | -14.15 | -274.26 | 507.54 | 7.70 | 13.23 | -0.56 |
| 8. | NACLIND | 174.00 | 329.49 | 4075.83 | 0.00 | 20.84 | 59.82 | 383.33 | -14.50 | 6.20 | 10.80 |
| 9. | BHAGCHEM | 290.25 | 136.75 | 3763.65 | 0.05 | 133.29 | 3249.84 | 1950.19 | 1475.55 | 4.55 | 15.65 |
| 10. | GSPCROP | 595.35 | 28.29 | 2769.49 | 0.17 | 263.94 | 1111.46 | 3859.95 | 1153.27 | 20.81 | 11.02 |
| 11. | BHARATRAS | 1279.90 | 14.85 | 2127.33 | 0.04 | 372.30 | 838.73 | 3381.60 | 796.03 | 16.63 | 15.19 |
| 12. | ASTEC | 604.15 | 0.00 | 1346.22 | 0.00 | -18.71 | 43.36 | 83.56 | -8.25 | -5.71 | -0.80 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 143 | 111 | 51 | 154 | 69 | 99 | 94 | 120 | 91 | 74 | 125 | 159 | 84 | |
| 140 | 114 | 69 | 141 | 116 | 118 | 100 | 114 | 102 | 80 | 121 | 149 | 103 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 2 | 1 | 1 | 2 | 1 | 2 | 2 | 1 | 0 | 1 | 1 | 3 | 1 |
| Interest | 6 | 6 | 6 | 7 | 7 | 9 | 10 | 10 | 11 | 8 | 7 | 8 | 8 |
| Depreciation | 9 | 9 | 9 | 9 | 9 | 11 | 11 | 12 | 12 | 10 | 11 | 12 | 11 |
| -11 | -18 | -32 | -1 | -62 | -39 | -25 | -16 | -33 | -24 | -16 | -8 | -19 | |
| Tax % | 25.66% | 23.75% | 24.50% | -3.12% | 35.56% | -0.00% | -60.44% | -2.61% | -0.00% | -0.00% | -0.00% | 2.02% | 0.22% |
| Net Profit | -8 | -13 | -24 | -1 | -40 | -39 | -40 | -16 | -33 | -24 | -16 | -8 | -19 |
| -4 | -7 | -12 | -0 | -20 | -20 | -21 | -8 | -17 | -11 | -7 | -3 | -1 | |
| Equity Capital | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 22 | 22 | 22 | 22 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 22 | 22 | 22 | 22 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 143
- 140
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 6
- Depreciation
- 9
- -11
- Tax %
- 25.66%
- Net Profit
- -8
- -4
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 111
- 114
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 6
- Depreciation
- 9
- -18
- Tax %
- 23.75%
- Net Profit
- -13
- -7
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 51
- 69
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 6
- Depreciation
- 9
- -32
- Tax %
- 24.50%
- Net Profit
- -24
- -12
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 154
- 141
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 7
- Depreciation
- 9
- -1
- Tax %
- -3.12%
- Net Profit
- -1
- -0
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 69
- 116
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 7
- Depreciation
- 9
- -62
- Tax %
- 35.56%
- Net Profit
- -40
- -20
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 99
- 118
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 9
- Depreciation
- 11
- -39
- Tax %
- -0.00%
- Net Profit
- -39
- -20
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 94
- 100
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 10
- Depreciation
- 11
- -25
- Tax %
- -60.44%
- Net Profit
- -40
- -21
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 120
- 114
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 10
- Depreciation
- 12
- -16
- Tax %
- -2.61%
- Net Profit
- -16
- -8
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 91
- 102
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 11
- Depreciation
- 12
- -33
- Tax %
- -0.00%
- Net Profit
- -33
- -17
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 20
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 74
- 80
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 8
- Depreciation
- 10
- -24
- Tax %
- -0.00%
- Net Profit
- -24
- -11
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 125
- 121
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 7
- Depreciation
- 11
- -16
- Tax %
- -0.00%
- Net Profit
- -16
- -7
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 159
- 149
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 8
- Depreciation
- 12
- -8
- Tax %
- 2.02%
- Net Profit
- -8
- -3
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 84
- 103
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 8
- Depreciation
- 11
- -19
- Tax %
- 0.22%
- Net Profit
- -19
- -1
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 313 | 371 | 431 | 522 | 555 | 677 | 628 | 458 | 381 | 448 | 441 | |
| 250 | 302 | 354 | 437 | 443 | 522 | 552 | 464 | 447 | 453 | 454 | |
| Operating Profit | 65 | 77 | 88 | 97 | 119 | 165 | 89 | -0 | -61 | 0 | — |
| OPM % | 21 | 21 | 20 | 19 | 21 | 24 | 14 | -0 | -16 | 0 | — |
| Other Income | 3 | 8 | 11 | 12 | 8 | 10 | 13 | 6 | 6 | 5 | 5 |
| Interest | 12 | 11 | 12 | 13 | 5 | 9 | 21 | 25 | 37 | 35 | 31 |
| Depreciation | 14 | 15 | 19 | 23 | 26 | 34 | 34 | 36 | 44 | 45 | 45 |
| 29 | 56 | 56 | 61 | 89 | 121 | 35 | -62 | -141 | -81 | -67 | |
| Tax % | 33 | 37 | 36 | 23 | 27 | 26 | 27 | 24 | 4 | 0 | 0 |
| Net Profit | 19 | 35 | 36 | 47 | 65 | 90 | 26 | -47 | -135 | -81 | -67 |
| EPS | 10 | 18 | 18 | 24 | 33 | 46 | 13 | -24 | -69 | -36 | — |
| Dividend Payout % | 15 | 8 | 8 | 6 | 5 | 3 | 12 | 0 | 0 | 0 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 10 | 18 | 18 | 24 | 33 | 45 | 13 | -24 | -68 | -36 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 10 | 18 | 18 | 24 | 33 | 45 | 13 | -24 | -68 | -36 | — |
Mar 2017
- 313
- 250
- Operating Profit
- 65
- OPM %
- 21
- Other Income
- 3
- Interest
- 12
- Depreciation
- 14
- 29
- Tax %
- 33
- Net Profit
- 19
- EPS
- 10
- Dividend Payout %
- 15
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 10
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 10
Mar 2018
- 371
- 302
- Operating Profit
- 77
- OPM %
- 21
- Other Income
- 8
- Interest
- 11
- Depreciation
- 15
- 56
- Tax %
- 37
- Net Profit
- 35
- EPS
- 18
- Dividend Payout %
- 8
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 18
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 18
Mar 2019
- 431
- 354
- Operating Profit
- 88
- OPM %
- 20
- Other Income
- 11
- Interest
- 12
- Depreciation
- 19
- 56
- Tax %
- 36
- Net Profit
- 36
- EPS
- 18
- Dividend Payout %
- 8
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 18
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 18
Mar 2020
- 522
- 437
- Operating Profit
- 97
- OPM %
- 19
- Other Income
- 12
- Interest
- 13
- Depreciation
- 23
- 61
- Tax %
- 23
- Net Profit
- 47
- EPS
- 24
- Dividend Payout %
- 6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 24
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 24
Mar 2021
- 555
- 443
- Operating Profit
- 119
- OPM %
- 21
- Other Income
- 8
- Interest
- 5
- Depreciation
- 26
- 89
- Tax %
- 27
- Net Profit
- 65
- EPS
- 33
- Dividend Payout %
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 33
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 33
Mar 2022
- 677
- 522
- Operating Profit
- 165
- OPM %
- 24
- Other Income
- 10
- Interest
- 9
- Depreciation
- 34
- 121
- Tax %
- 26
- Net Profit
- 90
- EPS
- 46
- Dividend Payout %
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 45
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 45
Mar 2023
- 628
- 552
- Operating Profit
- 89
- OPM %
- 14
- Other Income
- 13
- Interest
- 21
- Depreciation
- 34
- 35
- Tax %
- 27
- Net Profit
- 26
- EPS
- 13
- Dividend Payout %
- 12
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 13
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 13
Mar 2024
- 458
- 464
- Operating Profit
- -0
- OPM %
- -0
- Other Income
- 6
- Interest
- 25
- Depreciation
- 36
- -62
- Tax %
- 24
- Net Profit
- -47
- EPS
- -24
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -24
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -24
Mar 2025
- 381
- 447
- Operating Profit
- -61
- OPM %
- -16
- Other Income
- 6
- Interest
- 37
- Depreciation
- 44
- -141
- Tax %
- 4
- Net Profit
- -135
- EPS
- -69
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -68
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -68
Mar 2026
- 448
- 453
- Operating Profit
- 0
- OPM %
- 0
- Other Income
- 5
- Interest
- 35
- Depreciation
- 45
- -81
- Tax %
- 0
- Net Profit
- -81
- EPS
- -36
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -36
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -36
TTM
- 441
- 454
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 31
- Depreciation
- 45
- -67
- Tax %
- 0
- Net Profit
- -67
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 7%
- 5 Years:
- -4%
- 3 Years:
- -11%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- 4%
- 5 Years:
- -14%
- 3 Years:
- -24%
- 1 Year:
- -27%
RETURN ON EQUITY
- 10 Years:
- 5%
- 5 Years:
- -10%
- 3 Years:
- -28%
- Last Year:
- -26%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 22 |
| 118 | 149 | 182 | 226 | 289 | 376 | 399 | 349 | 214 | 367 | |
| 126 | 124 | 176 | 99 | 147 | 239 | 285 | 283 | 264 | 310 | |
| Trade Payables | 57 | 100 | 64 | 203 | 129 | 190 | 177 | 89 | 82 | 88 |
| 13 | 20 | 20 | 25 | 94 | 100 | 98 | 234 | 306 | 154 | |
| Total Liabilities | 334 | 413 | 461 | 572 | 678 | 925 | 979 | 974 | 886 | 941 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 103 | 115 | 167 | 194 | 213 | 340 | 318 | 386 | 499 | 459 | |
| Capital Work in Progress | 8 | 42 | 19 | 22 | 112 | 14 | 112 | 148 | 0 | 0 |
| 66 | 78 | 93 | 121 | 106 | 187 | 295 | 196 | 160 | 138 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 169 | 147 | 248 | |
| Cash & Bank | 4 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 11 |
| 153 | 176 | 181 | 233 | 245 | 383 | 251 | 73 | 78 | 85 | |
| Total Assets | 334 | 413 | 461 | 572 | 678 | 925 | 979 | 974 | 886 | 941 |
| Total Debt | 127 | 125 | 176 | 99 | 187 | 279 | 341 | 494 | 555 | 449 |
| Net Working Capital | 4 | -7 | -1 | 13 | 7 | 24 | -28 | 0 | -31 | -58 |
| Contingent Liabilities | 182 | 177 | 185 | 230 | 212 | 244 | 203 | 212 | 156 | 183 |
| Book Value per Share | 70.34 | 86.44 | 103.15 | 125.60 | 157.39 | 201.91 | 213.43 | 187.82 | 119.30 | 174.91 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 127 | 125 | 176 | 99 | 187 | 279 | 341 | 494 | 555 | 449 |
| Net Working Capital | 4 | -7 | -1 | 13 | 7 | 24 | -28 | 0 | -31 | -58 |
| Contingent Liabilities | 182 | 177 | 185 | 230 | 212 | 244 | 203 | 212 | 156 | 183 |
| Book Value per Share | 70.34 | 86.44 | 103.15 | 125.60 | 157.39 | 201.91 | 213.43 | 187.82 | 119.30 | 174.91 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2017
- Equity Capital
- 20
- 118
- 126
- Trade Payables
- 57
- 13
- Total Liabilities
- 334
- 103
- Capital Work in Progress
- 8
- 66
- 0
- Cash & Bank
- 4
- 153
- Total Assets
- 334
- Total Debt
- 127
- Net Working Capital
- 4
- Contingent Liabilities
- 182
- Book Value per Share
- 70.34
- Face Value
- 10.00
- Total Debt
- 127
- Net Working Capital
- 4
- Contingent Liabilities
- 182
- Book Value per Share
- 70.34
- Face Value
- 10.00
Mar 2018
- Equity Capital
- 20
- 149
- 124
- Trade Payables
- 100
- 20
- Total Liabilities
- 413
- 115
- Capital Work in Progress
- 42
- 78
- 0
- Cash & Bank
- 1
- 176
- Total Assets
- 413
- Total Debt
- 125
- Net Working Capital
- -7
- Contingent Liabilities
- 177
- Book Value per Share
- 86.44
- Face Value
- 10.00
- Total Debt
- 125
- Net Working Capital
- -7
- Contingent Liabilities
- 177
- Book Value per Share
- 86.44
- Face Value
- 10.00
Mar 2019
- Equity Capital
- 20
- 182
- 176
- Trade Payables
- 64
- 20
- Total Liabilities
- 461
- 167
- Capital Work in Progress
- 19
- 93
- 0
- Cash & Bank
- 1
- 181
- Total Assets
- 461
- Total Debt
- 176
- Net Working Capital
- -1
- Contingent Liabilities
- 185
- Book Value per Share
- 103.15
- Face Value
- 10.00
- Total Debt
- 176
- Net Working Capital
- -1
- Contingent Liabilities
- 185
- Book Value per Share
- 103.15
- Face Value
- 10.00
Mar 2020
- Equity Capital
- 20
- 226
- 99
- Trade Payables
- 203
- 25
- Total Liabilities
- 572
- 194
- Capital Work in Progress
- 22
- 121
- 0
- Cash & Bank
- 1
- 233
- Total Assets
- 572
- Total Debt
- 99
- Net Working Capital
- 13
- Contingent Liabilities
- 230
- Book Value per Share
- 125.60
- Face Value
- 10.00
- Total Debt
- 99
- Net Working Capital
- 13
- Contingent Liabilities
- 230
- Book Value per Share
- 125.60
- Face Value
- 10.00
Mar 2021
- Equity Capital
- 20
- 289
- 147
- Trade Payables
- 129
- 94
- Total Liabilities
- 678
- 213
- Capital Work in Progress
- 112
- 106
- 0
- Cash & Bank
- 2
- 245
- Total Assets
- 678
- Total Debt
- 187
- Net Working Capital
- 7
- Contingent Liabilities
- 212
- Book Value per Share
- 157.39
- Face Value
- 10.00
- Total Debt
- 187
- Net Working Capital
- 7
- Contingent Liabilities
- 212
- Book Value per Share
- 157.39
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 20
- 376
- 239
- Trade Payables
- 190
- 100
- Total Liabilities
- 925
- 340
- Capital Work in Progress
- 14
- 187
- 0
- Cash & Bank
- 2
- 383
- Total Assets
- 925
- Total Debt
- 279
- Net Working Capital
- 24
- Contingent Liabilities
- 244
- Book Value per Share
- 201.91
- Face Value
- 10.00
- Total Debt
- 279
- Net Working Capital
- 24
- Contingent Liabilities
- 244
- Book Value per Share
- 201.91
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 20
- 399
- 285
- Trade Payables
- 177
- 98
- Total Liabilities
- 979
- 318
- Capital Work in Progress
- 112
- 295
- 0
- Cash & Bank
- 1
- 251
- Total Assets
- 979
- Total Debt
- 341
- Net Working Capital
- -28
- Contingent Liabilities
- 203
- Book Value per Share
- 213.43
- Face Value
- 10.00
- Total Debt
- 341
- Net Working Capital
- -28
- Contingent Liabilities
- 203
- Book Value per Share
- 213.43
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 20
- 349
- 283
- Trade Payables
- 89
- 234
- Total Liabilities
- 974
- 386
- Capital Work in Progress
- 148
- 196
- 169
- Cash & Bank
- 1
- 73
- Total Assets
- 974
- Total Debt
- 494
- Net Working Capital
- 0
- Contingent Liabilities
- 212
- Book Value per Share
- 187.82
- Face Value
- 10.00
- Total Debt
- 494
- Net Working Capital
- 0
- Contingent Liabilities
- 212
- Book Value per Share
- 187.82
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 20
- 214
- 264
- Trade Payables
- 82
- 306
- Total Liabilities
- 886
- 499
- Capital Work in Progress
- 0
- 160
- 147
- Cash & Bank
- 1
- 78
- Total Assets
- 886
- Total Debt
- 555
- Net Working Capital
- -31
- Contingent Liabilities
- 156
- Book Value per Share
- 119.30
- Face Value
- 10.00
- Total Debt
- 555
- Net Working Capital
- -31
- Contingent Liabilities
- 156
- Book Value per Share
- 119.30
- Face Value
- 10.00
Mar 2026
- Equity Capital
- 22
- 367
- 310
- Trade Payables
- 88
- 154
- Total Liabilities
- 941
- 459
- Capital Work in Progress
- 0
- 138
- 248
- Cash & Bank
- 11
- 85
- Total Assets
- 941
- Total Debt
- 449
- Net Working Capital
- -58
- Contingent Liabilities
- 183
- Book Value per Share
- 174.91
- Face Value
- 10.00
- Total Debt
- 449
- Net Working Capital
- -58
- Contingent Liabilities
- 183
- Book Value per Share
- 174.91
- Face Value
- 10.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 19 | 65 | 15 | 169 | -8 | 23 | 74 | 10 | -8 | -81 | |
| Cash from Investing | -18 | -49 | -52 | -74 | -73 | -104 | -112 | -135 | -15 | -4 |
| Cash from Financing | -1 | -18 | 37 | -95 | 81 | 80 | 38 | 125 | 24 | 94 |
| 1 | -2 | -0 | 0 | 0 | 0 | -0 | 0 | 0 | 9 | |
| Free Cash Flow | 10 | 5 | -33 | 115 | -142 | -40 | -35 | -130 | -17 | -86 |
| OCF / Net Profit | 1.00 | 1.85 | 0.43 | 3.55 | -0.12 | 0.26 | 2.91 | -0.22 | 0.06 | 0.99 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | -45 | -95 | -135 | -233 | -365 | -309 |
| OCF / Net Profit | 1.00 | 1.85 | 0.43 | 3.55 | -0.12 | 0.26 | 2.91 | -0.22 | 0.06 | 0.99 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | -45 | -95 | -135 | -233 | -365 | -309 |
Mar 2017
- 19
- Cash from Investing
- -18
- Cash from Financing
- -1
- 1
- Free Cash Flow
- 10
- OCF / Net Profit
- 1.00
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.00
- Cumulative 5-Year FCF
- 0
Mar 2018
- 65
- Cash from Investing
- -49
- Cash from Financing
- -18
- -2
- Free Cash Flow
- 5
- OCF / Net Profit
- 1.85
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.85
- Cumulative 5-Year FCF
- 0
Mar 2019
- 15
- Cash from Investing
- -52
- Cash from Financing
- 37
- -0
- Free Cash Flow
- -33
- OCF / Net Profit
- 0.43
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.43
- Cumulative 5-Year FCF
- 0
Mar 2020
- 169
- Cash from Investing
- -74
- Cash from Financing
- -95
- 0
- Free Cash Flow
- 115
- OCF / Net Profit
- 3.55
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 3.55
- Cumulative 5-Year FCF
- 0
Mar 2021
- -8
- Cash from Investing
- -73
- Cash from Financing
- 81
- 0
- Free Cash Flow
- -142
- OCF / Net Profit
- -0.12
- Cumulative 5-Year FCF
- -45
- OCF / Net Profit
- -0.12
- Cumulative 5-Year FCF
- -45
Mar 2022
- 23
- Cash from Investing
- -104
- Cash from Financing
- 80
- 0
- Free Cash Flow
- -40
- OCF / Net Profit
- 0.26
- Cumulative 5-Year FCF
- -95
- OCF / Net Profit
- 0.26
- Cumulative 5-Year FCF
- -95
Mar 2023
- 74
- Cash from Investing
- -112
- Cash from Financing
- 38
- -0
- Free Cash Flow
- -35
- OCF / Net Profit
- 2.91
- Cumulative 5-Year FCF
- -135
- OCF / Net Profit
- 2.91
- Cumulative 5-Year FCF
- -135
Mar 2024
- 10
- Cash from Investing
- -135
- Cash from Financing
- 125
- 0
- Free Cash Flow
- -130
- OCF / Net Profit
- -0.22
- Cumulative 5-Year FCF
- -233
- OCF / Net Profit
- -0.22
- Cumulative 5-Year FCF
- -233
Mar 2025
- -8
- Cash from Investing
- -15
- Cash from Financing
- 24
- 0
- Free Cash Flow
- -17
- OCF / Net Profit
- 0.06
- Cumulative 5-Year FCF
- -365
- OCF / Net Profit
- 0.06
- Cumulative 5-Year FCF
- -365
Mar 2026
- -81
- Cash from Investing
- -4
- Cash from Financing
- 94
- 9
- Free Cash Flow
- -86
- OCF / Net Profit
- 0.99
- Cumulative 5-Year FCF
- -309
- OCF / Net Profit
- 0.99
- Cumulative 5-Year FCF
- -309
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 9.79 | 17.91 | 18.25 | 24.26 | 33.03 | 45.83 | 13.02 | -23.96 | -68.74 | -36.36 |
| Book Value (₹) | 70.34 | 86.44 | 103.15 | 125.60 | 157.39 | 201.91 | 213.43 | 187.82 | 119.30 | 174.91 |
| Dividend per Share (₹) | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 16.67 | 25.24 | 27.94 | 35.87 | 45.82 | 62.93 | 29.99 | -5.40 | -46.08 | -16.16 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 20.83% | 20.72% | 20.23% | 18.49% | 21.33% | 24.20% | 14.15% | -1.29% | -17.00% | -1.00% |
| Net Margin % | 6.11% | 9.43% | 8.25% | 9.04% | 11.58% | 13.21% | 4.04% | -10.23% | -34.62% | -18.05% |
| ROE % | 14.99% | 22.85% | 19.26% | 21.22% | 23.35% | 25.52% | 6.27% | -11.94% | -44.77% | -25.98% |
| ROCE % | 16.03% | 23.74% | 20.28% | 20.44% | 22.22% | 22.22% | 7.75% | -4.52% | -12.65% | -5.73% |
| 5.78% | 9.37% | 8.16% | 9.19% | 10.35% | 11.20% | 2.68% | -4.81% | -14.50% | -8.87% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 111 | 115 | 103 | 98 | 114 | 124 | 124 | 129 | 148 | 161 |
| Inventory Days | 80 | 71 | 72 | 74 | 74 | 79 | 139 | 195 | 167 | 121 |
| Payable Days | 118 | 121 | 107 | 144 | 177 | 151 | 167 | 152 | 105 | 103 |
| 73 | 65 | 69 | 29 | 11 | 52 | 96 | 171 | 210 | 178 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.92x | 0.74x | 0.87x | 0.40x | 0.61x | 0.71x | 0.82x | 1.34x | 2.37x | 1.15x |
| Interest Coverage (x) | 3.34x | 6.22x | 5.51x | 5.85x | 19.51x | 14.32x | 2.68x | -1.45x | -2.84x | -1.35x |
| 1.02x | 0.97x | 1.00x | 1.04x | 1.02x | 1.05x | 0.95x | 1.00x | 0.92x | 0.88x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | 32.98% | 18.57% | 16.19% | 21.19% | 6.25% | 21.93% | -7.15% | -27.06% | -16.78% | 17.53% |
| Operating Profit Growth % | 93.86% | 18.00% | 13.86% | 11.00% | 22.69% | 38.07% | -45.73% | -100.36% | 0.00% | 100.80% |
| Net Profit Growth % | 5296.89% | 83.15% | 2.05% | 33.03% | 36.28% | 38.84% | -71.59% | -284.12% | -186.90% | 39.91% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -284.08% | -186.87% | 47.11% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 5.65x | 5.66x | 3.08x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | -8069.87x | -30.95x | 3392.35x |
Mar 2017
- EPS (₹)
- 9.79
- Book Value (₹)
- 70.34
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 16.67
- Operating Margin %
- 20.83%
- Net Margin %
- 6.11%
- ROE %
- 14.99%
- ROCE %
- 16.03%
- 5.78%
- Debtor Days
- 111
- Inventory Days
- 80
- Payable Days
- 118
- 73
- Debt to Equity (x)
- 0.92x
- Interest Coverage (x)
- 3.34x
- 1.02x
- Revenue Growth %
- 32.98%
- Operating Profit Growth %
- 93.86%
- Net Profit Growth %
- 5296.89%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 17.91
- Book Value (₹)
- 86.44
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 25.24
- Operating Margin %
- 20.72%
- Net Margin %
- 9.43%
- ROE %
- 22.85%
- ROCE %
- 23.74%
- 9.37%
- Debtor Days
- 115
- Inventory Days
- 71
- Payable Days
- 121
- 65
- Debt to Equity (x)
- 0.74x
- Interest Coverage (x)
- 6.22x
- 0.97x
- Revenue Growth %
- 18.57%
- Operating Profit Growth %
- 18.00%
- Net Profit Growth %
- 83.15%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 18.25
- Book Value (₹)
- 103.15
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 27.94
- Operating Margin %
- 20.23%
- Net Margin %
- 8.25%
- ROE %
- 19.26%
- ROCE %
- 20.28%
- 8.16%
- Debtor Days
- 103
- Inventory Days
- 72
- Payable Days
- 107
- 69
- Debt to Equity (x)
- 0.87x
- Interest Coverage (x)
- 5.51x
- 1.00x
- Revenue Growth %
- 16.19%
- Operating Profit Growth %
- 13.86%
- Net Profit Growth %
- 2.05%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 24.26
- Book Value (₹)
- 125.60
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 35.87
- Operating Margin %
- 18.49%
- Net Margin %
- 9.04%
- ROE %
- 21.22%
- ROCE %
- 20.44%
- 9.19%
- Debtor Days
- 98
- Inventory Days
- 74
- Payable Days
- 144
- 29
- Debt to Equity (x)
- 0.40x
- Interest Coverage (x)
- 5.85x
- 1.04x
- Revenue Growth %
- 21.19%
- Operating Profit Growth %
- 11.00%
- Net Profit Growth %
- 33.03%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 33.03
- Book Value (₹)
- 157.39
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 45.82
- Operating Margin %
- 21.33%
- Net Margin %
- 11.58%
- ROE %
- 23.35%
- ROCE %
- 22.22%
- 10.35%
- Debtor Days
- 114
- Inventory Days
- 74
- Payable Days
- 177
- 11
- Debt to Equity (x)
- 0.61x
- Interest Coverage (x)
- 19.51x
- 1.02x
- Revenue Growth %
- 6.25%
- Operating Profit Growth %
- 22.69%
- Net Profit Growth %
- 36.28%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 45.83
- Book Value (₹)
- 201.91
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 62.93
- Operating Margin %
- 24.20%
- Net Margin %
- 13.21%
- ROE %
- 25.52%
- ROCE %
- 22.22%
- 11.20%
- Debtor Days
- 124
- Inventory Days
- 79
- Payable Days
- 151
- 52
- Debt to Equity (x)
- 0.71x
- Interest Coverage (x)
- 14.32x
- 1.05x
- Revenue Growth %
- 21.93%
- Operating Profit Growth %
- 38.07%
- Net Profit Growth %
- 38.84%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 13.02
- Book Value (₹)
- 213.43
- Dividend per Share (₹)
- 1.50
- Cash EPS (₹)
- 29.99
- Operating Margin %
- 14.15%
- Net Margin %
- 4.04%
- ROE %
- 6.27%
- ROCE %
- 7.75%
- 2.68%
- Debtor Days
- 124
- Inventory Days
- 139
- Payable Days
- 167
- 96
- Debt to Equity (x)
- 0.82x
- Interest Coverage (x)
- 2.68x
- 0.95x
- Revenue Growth %
- -7.15%
- Operating Profit Growth %
- -45.73%
- Net Profit Growth %
- -71.59%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- -23.96
- Book Value (₹)
- 187.82
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -5.40
- Operating Margin %
- -1.29%
- Net Margin %
- -10.23%
- ROE %
- -11.94%
- ROCE %
- -4.52%
- -4.81%
- Debtor Days
- 129
- Inventory Days
- 195
- Payable Days
- 152
- 171
- Debt to Equity (x)
- 1.34x
- Interest Coverage (x)
- -1.45x
- 1.00x
- Revenue Growth %
- -27.06%
- Operating Profit Growth %
- -100.36%
- Net Profit Growth %
- -284.12%
- -284.08%
- P/E (x)
- 0.00x
- P/B (x)
- 5.65x
- Dividend Yield %
- 0.00%
- -8069.87x
Mar 2025
- EPS (₹)
- -68.74
- Book Value (₹)
- 119.30
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -46.08
- Operating Margin %
- -17.00%
- Net Margin %
- -34.62%
- ROE %
- -44.77%
- ROCE %
- -12.65%
- -14.50%
- Debtor Days
- 148
- Inventory Days
- 167
- Payable Days
- 105
- 210
- Debt to Equity (x)
- 2.37x
- Interest Coverage (x)
- -2.84x
- 0.92x
- Revenue Growth %
- -16.78%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- -186.90%
- -186.87%
- P/E (x)
- 0.00x
- P/B (x)
- 5.66x
- Dividend Yield %
- 0.00%
- -30.95x
Mar 2026
- EPS (₹)
- -36.36
- Book Value (₹)
- 174.91
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -16.16
- Operating Margin %
- -1.00%
- Net Margin %
- -18.05%
- ROE %
- -25.98%
- ROCE %
- -5.73%
- -8.87%
- Debtor Days
- 161
- Inventory Days
- 121
- Payable Days
- 103
- 178
- Debt to Equity (x)
- 1.15x
- Interest Coverage (x)
- -1.35x
- 0.88x
- Revenue Growth %
- 17.53%
- Operating Profit Growth %
- 100.80%
- Net Profit Growth %
- 39.91%
- 47.11%
- P/E (x)
- 0.00x
- P/B (x)
- 3.08x
- Dividend Yield %
- 0.00%
- 3392.35x
Documents
Announcements
- Copy of Newspaper Publication
2026-08-01 - Astec LifeSciences Limited has informed the Exchange about Copy of Newspaper Publication
- Updates
2026-07-31 - Astec LifeSciences Limited has informed the Exchange regarding 'Adoption of Annual Report 2025-26 by the Shareholders at the AGM held on 31st July, 2026.'.
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Nov 2022
May 2022
Nov 2021